Rare diseases
Investigational molecules
Locations
Study on Glofitamab and Drug Combination for Children and Young Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ItalyStudy on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria
ItalyStudy Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera
ItalyStudy on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis
ItalyStudy on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors
ItalyStudy on the Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer
ItalyStudy of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion
ItalyStudy on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients
ItalyStudy on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy
ItalyStudy on the Safety and Effectiveness of Lufepirsen Gel for Patients with Persistent Corneal Epithelial Defects
ItalyStudy on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis
ItalyLong-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
